Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Adienne
Adienne
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Phelinun
Melphalan
2020-11-16
2029-2036
Myeloid leukemia acute
,
Breast neoplasms
,
Ovarian neoplasms
,
Non-hodgkin lymphoma
,
Multiple myeloma
,
Neuroblastoma
,
Precursor cell lymphoblastic leukemia-lymphoma
,
Hematopoietic stem cell transplantation
,
Hodgkin disease
,
Rhabdomyosarcoma
Tepadina
Thiotepa
2017-01-26
Breast neoplasms
,
Ovarian neoplasms
,
Sarcoma
,
Lymphoma
,
Urinary bladder neoplasms
,
Hematopoietic stem cell transplantation
,
Adenocarcinoma
,
Neoplasms
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Thiotepa
lymphoma
,
leukemia
,
myelodysplastic syndromes
,
myeloid leukemia acute
,
myeloid leukemia
Mycophenolate sodium
immunosuppression therapy
,
healthy volunteers/patients
,
vasculitis
,
microscopic polyangiitis
,
systemic vasculitis
,
congenital abnormalities
,
urologic diseases
,
chronic kidney failure
,
systemic scleroderma
,
localized scleroderma
,
diffuse scleroderma
,
myelodysplastic syndromes
,
preleukemia
,
syndrome
,
diabetes mellitus
,
hypoglycemia
,
lung diseases
,
interstitial lung diseases
,
hypertension
,
iga glomerulonephritis
,
renal hypertension
,
bullous pemphigoid
,
psoriasis
,
lupus nephritis
,
nephritis
,
systemic lupus erythematosus
,
type 1 diabetes mellitus
,
neuromyelitis optica
,
pemphigus
,
myasthenia gravis
,
muscle weakness
,
diabetic nephropathies
,
glomerulonephritis
,
multiple sclerosis
,
sclerosis
,
cardiovascular diseases
,
lung transplantation
,
sarcoidosis
,
pulmonary sarcoidosis
,
membranous glomerulonephritis
,
kidney transplantation
,
kidney diseases
,
liver transplantation
,
heart transplantation
,
renal insufficiency
,
polyomavirus infections
,
corneal transplantation
,
liver diseases
,
hiv infections
,
graft vs host disease
,
hematopoietic stem cell transplantation
Mycophenolic acid
immunosuppression therapy
,
healthy volunteers/patients
,
vasculitis
,
microscopic polyangiitis
,
systemic vasculitis
,
congenital abnormalities
,
urologic diseases
,
chronic kidney failure
,
systemic scleroderma
,
localized scleroderma
,
diffuse scleroderma
,
myelodysplastic syndromes
,
preleukemia
,
syndrome
,
diabetes mellitus
,
hypoglycemia
,
lung diseases
,
interstitial lung diseases
,
hypertension
,
iga glomerulonephritis
,
renal hypertension
,
bullous pemphigoid
,
psoriasis
,
lupus nephritis
,
nephritis
,
systemic lupus erythematosus
,
type 1 diabetes mellitus
,
neuromyelitis optica
,
pemphigus
,
myasthenia gravis
,
muscle weakness
,
diabetic nephropathies
,
glomerulonephritis
,
multiple sclerosis
,
sclerosis
,
cardiovascular diseases
,
lung transplantation
,
sarcoidosis
,
pulmonary sarcoidosis
,
membranous glomerulonephritis
,
kidney transplantation
,
heart transplantation
,
kidney diseases
,
liver transplantation
,
renal insufficiency
,
polyomavirus infections
,
corneal transplantation
,
delayed graft function
,
liver diseases
,
hiv infections
,
graft vs host disease
,
hematopoietic stem cell transplantation
Begelomab
graft vs host disease
Globulin, immune
renal cell carcinoma
,
neoplasms
,
non-small-cell lung carcinoma
,
urinary bladder neoplasms
,
melanoma
,
oncogenes
,
fabry disease
,
urologic neoplasms
,
carcinoma
,
transitional cell carcinoma
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use